Tag: biosimilars
Specialty Pharmacy: The Provider's Role in Dispensing Generic Specialty Drugs
Explore why generic specialty drugs and biosimilars still require specialty pharmacy dispensing. Learn about the provider's role in managing prior authorizations, patient transitions, and complex care workflows.
Future Biosimilars: Upcoming Patent Expirations and Market Entry
Biosimilars are set to transform healthcare as major biologics like Keytruda and Eylea lose patent protection. With billions in savings on the horizon, learn how these complex drugs are entering the market and what it means for patients and providers.